Home

Thank you for visiting SEAK Therapeutics, LLC. This site is under construction and I hope you can come back to visit us again.

About SEAK Therapeutics LLC

SEAK Therapeutics LLC is a start up company founded in November 2018 by Dr. Wei Li. The goal of SEAK is to develop a new targeted small-molecule drug for cancers or neurological diseases where the target is expressed/over-activated.

Funding and Products

SEAK Therapeutics is still in its early stages of development, and we greatly appreciate the supports from the NIH SBIR/STTR grant programs, the LanuchTN matching grant programs, and other sources of funding.

SEAK Therapeutics welcomes Angel Investments and other supports. Please contact Dr. Wei Li at wli.uthsc@gmail.com for additional information. Thank you for your visit.

Contact

Email: wli.uthsc@gmail.com